Dispositivo intrauterino liberador de levonorgestrel (DIU Mirena®) y miomas. Efectos clínicos

Comparison of the initial and final volume of the myomas in the sonographic follow-up showed that the volume decreased in 15/27 myomas (55.55%) and in 12/16 intramural myomas (44.44%).